MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This study examine the efficacy of oral magnesium supplementation as an adjuvant therapy for
decreasing intensity of alcohol withdrawal symptoms among inpatients requiring
pharmacological treatment of their AWS. This double blind randomized multicenter clinical
trial planned to treat half of participants as usal plus placebo and the other half as usual
plus magnesium.